Literature DB >> 20466976

The mouse atherosclerosis locus at chromosome 10 (Ath11) acts early in lesion formation with subcongenic strains delineating 2 narrowed regions.

Susanne Wolfrum1, José M Rodríguez, Marietta Tan, Kwan Y Chen, Daniel Teupser, Jan L Breslow.   

Abstract

OBJECTIVE: Ath11, an atherosclerosis susceptibility locus on proximal chromosome 10 (0 to 21 cM) revealed in a cross between apolipoprotein E deficient C57BL/6 (B6) and FVB mice, was recently confirmed in congenic mice. The objectives of this study were to assess how Ath11 affects lesion development and morphology, to determine aortic gene expression in congenics, and to narrow the congenic interval. METHODS AND
RESULTS: Assessing lesion area over time in congenic mice showed that homozygosity for the FVB allele increased lesion area at 6 weeks persisting through to 24 weeks of age. Staining of aortic root sections at 16 weeks did not reveal obvious differences between congenics. Aortic expression-array analysis at 6 weeks revealed 97 genes that were >2-fold regulated, including 1 gene in the quantitative trait locus interval, Aldh8a1, and 2 gene clusters regulated by Hnf4alpha and Esr1. Analysis of lesion area in 11 subcongenic strains revealed 2 narrowed regions, 10a (21 genes), acting in females, and 10b (7 genes), acting in both genders.
CONCLUSIONS: Ath11 appears to act early in lesion formation, with significant effects on aortic gene expression. This quantitative trait locus is genetically complex, containing a female-specific region 10a from 0 to 7.3 megabases (21 genes) and a gender-independent region 10b from 20.1 to 21.9 megabases (7 genes).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466976      PMCID: PMC2917113          DOI: 10.1161/ATVBAHA.110.205757

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice.

Authors:  M M Marsh; V R Walker; L K Curtiss; C L Banka
Journal:  J Lipid Res       Date:  1999-05       Impact factor: 5.922

Review 2.  Finding genes that underlie complex traits.

Authors:  Anne M Glazier; Joseph H Nadeau; Timothy J Aitman
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

3.  17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice.

Authors:  R Elhage; J F Arnal; M T Pieraggi; N Duverger; C Fiévet; J C Faye; F Bayard
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

4.  Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice.

Authors:  J B Hodgin; J H Krege; R L Reddick; K S Korach; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

5.  Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.

Authors:  Judith Hsia; Michael H Criqui; David M Herrington; Joann E Manson; Lieling Wu; Susan R Heckbert; Matthew Allison; Mary McGrae McDermott; Jennifer Robinson; Kamal Masaki
Journal:  Am Heart J       Date:  2006-07       Impact factor: 4.749

6.  Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice.

Authors:  Daniel Teupser; Marietta Tan; Adam D Persky; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

7.  A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse.

Authors:  Hayes M Dansky; Pei Shu; M Donavan; Jill Montagno; Deborah L Nagle; John S Smutko; Natalie Roy; S Whiteing; Judith Barrios; T J McBride; Jonathan D Smith; Geoffrey Duyk; Jan L Breslow; Karen J Moore
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

8.  Novel strategy using F1-congenic mice for validation of QTLs: studies at the proximal chromosome 10 atherosclerosis susceptibility locus.

Authors:  Daniel Teupser; Susanne Wolfrum; Marietta Tan; Adam D Persky; Hayes M Dansky; Jan L Breslow
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-26       Impact factor: 8.311

9.  Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).

Authors:  Daniel Teupser; Adam D Persky; Jan L Breslow
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-07       Impact factor: 8.311

10.  Molecular definition of breast tumor heterogeneity.

Authors:  Michail Shipitsin; Lauren L Campbell; Pedram Argani; Stanislawa Weremowicz; Noga Bloushtain-Qimron; Jun Yao; Tatiana Nikolskaya; Tatiana Serebryiskaya; Rameen Beroukhim; Min Hu; Marc K Halushka; Saraswati Sukumar; Leroy M Parker; Karen S Anderson; Lyndsay N Harris; Judy E Garber; Andrea L Richardson; Stuart J Schnitt; Yuri Nikolsky; Rebecca S Gelman; Kornelia Polyak
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

View more
  7 in total

1.  Genetics of common forms of heart disease: a long and winding road.

Authors:  Carrie Welch; Aldons J Lusis
Journal:  Circ Res       Date:  2013-10-12       Impact factor: 17.367

2.  Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.

Authors:  Vicent Ribas; Brian G Drew; Jamie A Le; Teo Soleymani; Pedram Daraei; Daniel Sitz; Laila Mohammad; Darren C Henstridge; Mark A Febbraio; Sylvia C Hewitt; Kenneth S Korach; Steven J Bensinger; Andrea L Hevener
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-07       Impact factor: 11.205

3.  Beyond genome-wide association studies: the usefulness of mouse genetics in understanding the complex etiology of atherosclerosis.

Authors:  Carrie L Welch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02       Impact factor: 8.311

4.  Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b.

Authors:  José M Rodríguez; Susanne Wolfrum; Megan Robblee; Kwan Y Chen; Zachary N Gilbert; Jae-Hoon Choi; Daniel Teupser; Jan L Breslow
Journal:  Circ Res       Date:  2013-08-15       Impact factor: 17.367

5.  Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice.

Authors:  Ryoko Okamoto; Sigal Gery; Adrian F Gombart; Xuping Wang; Lawrence W Castellani; Tadayuki Akagi; Shuang Chen; Moshe Arditi; Quoc Ho; Aldons J Lusis; Quanlin Li; H Phillip Koeffler
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Sequencing and characterization of the FVB/NJ mouse genome.

Authors:  Kim Wong; Suzannah Bumpstead; Louise Van Der Weyden; Laura G Reinholdt; Laurens G Wilming; David J Adams; Thomas M Keane
Journal:  Genome Biol       Date:  2012-08-23       Impact factor: 13.583

7.  Quantitative trait loci affecting atherosclerosis at the aortic root identified in an intercross between DBA2J and 129S6 apolipoprotein E-null mice.

Authors:  Yukako Kayashima; Hirofumi Tomita; Svetlana Zhilicheva; Shinja Kim; Hyung-Suk Kim; Brian J Bennett; Nobuyo Maeda
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.